These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1003 related articles for article (PubMed ID: 28938961)
1. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department. Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL; Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961 [TBL] [Abstract][Full Text] [Related]
2. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study. Januzzi JL; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Rivers EJ; Walters EL; Gaggin HK; J Am Coll Cardiol; 2018 Mar; 71(11):1191-1200. PubMed ID: 29544601 [TBL] [Abstract][Full Text] [Related]
3. Combination of quantitative capnometry, N-terminal pro-brain natriuretic peptide, and clinical assessment in differentiating acute heart failure from pulmonary disease as cause of acute dyspnea in pre-hospital emergency setting: study of diagnostic accuracy. Klemen P; Golub M; Grmec S Croat Med J; 2009 Apr; 50(2):133-42. PubMed ID: 19399946 [TBL] [Abstract][Full Text] [Related]
4. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644 [TBL] [Abstract][Full Text] [Related]
5. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303 [TBL] [Abstract][Full Text] [Related]
6. Economic Evaluation of an N-terminal Pro B-type Natriuretic Peptide-Supported Diagnostic Strategy Among Dyspneic Patients Suspected of Acute Heart Failure in the Emergency Department. Siebert U; Milev S; Zou D; Litkiewicz M; Gaggin HK; Tirapelle L; Masson S; Januzzi JL Am J Cardiol; 2021 May; 147():61-69. PubMed ID: 33617809 [TBL] [Abstract][Full Text] [Related]
7. Influence of glycosylation on diagnostic and prognostic accuracy of N-terminal pro-B-type natriuretic peptide in acute dyspnea: data from the Akershus Cardiac Examination 2 Study. Røsjø H; Dahl MB; Jørgensen M; Røysland R; Brynildsen J; Cataliotti A; Christensen G; Høiseth AD; Hagve TA; Omland T Clin Chem; 2015 Aug; 61(8):1087-97. PubMed ID: 26056354 [TBL] [Abstract][Full Text] [Related]
8. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Januzzi JL; van Kimmenade R; Lainchbury J; Bayes-Genis A; Ordonez-Llanos J; Santalo-Bel M; Pinto YM; Richards M Eur Heart J; 2006 Feb; 27(3):330-7. PubMed ID: 16293638 [TBL] [Abstract][Full Text] [Related]
9. Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Krauser DG; Chen AA; Tung R; Anwaruddin S; Baggish AL; Januzzi JL J Card Fail; 2006 Aug; 12(6):452-7. PubMed ID: 16911912 [TBL] [Abstract][Full Text] [Related]
10. Potential impact of N-terminal pro-BNP testing on the emergency department evaluation of acute dyspnea. Murray H; Cload B; Collier CP; Sivilotti ML CJEM; 2006 Jul; 8(4):251-8. PubMed ID: 17324304 [TBL] [Abstract][Full Text] [Related]
11. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Januzzi JL; Chen-Tournoux AA; Moe G Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855 [TBL] [Abstract][Full Text] [Related]
12. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure. Baggish AL; van Kimmenade RR; Januzzi JL Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859 [TBL] [Abstract][Full Text] [Related]
13. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921 [TBL] [Abstract][Full Text] [Related]
14. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea. Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868 [TBL] [Abstract][Full Text] [Related]
15. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387 [TBL] [Abstract][Full Text] [Related]
16. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287 [TBL] [Abstract][Full Text] [Related]
17. Emergency thoracic ultrasound in the differentiation of the etiology of shortness of breath (ETUDES): sonographic B-lines and N-terminal pro-brain-type natriuretic peptide in diagnosing congestive heart failure. Liteplo AS; Marill KA; Villen T; Miller RM; Murray AF; Croft PE; Capp R; Noble VE Acad Emerg Med; 2009 Mar; 16(3):201-10. PubMed ID: 19183402 [TBL] [Abstract][Full Text] [Related]
18. Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I. Hoffmann U; Espeter F; Weiß C; Ahmad-Nejad P; Lang S; Brueckmann M; Akin I; Neumaier M; Borggrefe M; Behnes M BMC Cardiovasc Disord; 2015 Jun; 15():50. PubMed ID: 26072112 [TBL] [Abstract][Full Text] [Related]
19. A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score. Baggish AL; Siebert U; Lainchbury JG; Cameron R; Anwaruddin S; Chen A; Krauser DG; Tung R; Brown DF; Richards AM; Januzzi JL Am Heart J; 2006 Jan; 151(1):48-54. PubMed ID: 16368291 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema. Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]